Havila Kystruten AS | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Havila Kystruten AS

BRIEF

published on 06/03/2024 at 18:36, 5 months 17 days ago

Montega AG Reaffirms Buy Rating for Havila Kystruten AS Despite Q1 Miss

Montega AG Target Price Q1 2024 Earnings Cruise Industry Havila Kystruten
PRESS RELEASE

published on 06/03/2024 at 18:31, 5 months 17 days ago

Original-Research: Havila Kystruten AS (von Montega AG): Kaufen
Havila Kystruten AS reports Q1 2024 results: sales below expectations, EBITDA negative, focusing on improving ACR and streamlining operations. Positive industry outlook

EBITDA Havila Kystruten AS Q1 2024 Results Industry Outlook Sales Performance
PRESS RELEASE

published on 02/05/2024 at 17:46, 9 months 15 days ago

Original-Research: Havila Kystruten AS (von Montega AG): Buy
Montega AG initiates coverage on Havila Kystruten AS with a Buy recommendation and a price target of 2.80 NOK per share. The cruise line operator is poised to outperform its rival due to a modern fleet, strong government support, and favorable industry dynamics

Buy Recommendation Havila Kystruten AS Cruise Line Operator Coverage Initiation Norwegian Coast

Accesswire

Published on 11/21/2024 at 10:03, 51 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 54 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 54 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 19 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 29 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 24 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 49 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 52 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 54 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 54 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 56 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 34 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 9 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 9 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE